Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Pfizer and Takeda to Co-Promote Rheumatoid Arthritis Products in Japan

By Pharmaceutical Processing | February 4, 2011

Pfizer Japan Inc. and Takeda Pharmaceutical Company Limited
announced today an agreement to extend the period for co-promotion in Japan for
the rheumatoid arthritis (RA) drug Enbrel(R) (generic name: etanercept). The
companies also signed a new co-promotion agreement in Japan for the
investigational drug tofacitinib (development code: CP-690,550), formerly known
as tasocitinib, which is being studied for multiple inflammatory conditions,
including rheumatoid arthritis. The co-promotion agreement between Takeda and
Pfizer for Tofacitinib is for RA and certain other potential indications in Japan. Pfizer
will receive a milestone payment from Takeda at the launch of Tofacitinib and
Takeda will receive a percentage of sales (based on certain conditions
specified in the contract) as a co-promotion fee from Pfizer. Contractual
details are not disclosed.

“We are looking forward to the next phase of our
successful partnership with Takeda,” said Michael Goettler, regional
president of Asia-Pacific and Japan Head, Specialty Care Business Unit, Pfizer.
“We are proud of our current inflammation product portfolio, and excited about
the prospect of bringing new innovative treatments to our patients.”

 

Related Articles Read More >

Astellas
Astellas to spend $70M on new biotech campus in South San Francisco
Rainin
Mettler Toledo Rainin expands facilities in Vacaville, California
Elemental Machines
Elemental Machines aims to enlist lab freezers in fight against climate change 
Pfizer logo
Pfizer seeks to comply with voluntary Net-Zero Standard by 2040

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards